2.10

5.41% -0.12

After Hours: 2.11 0.010 +0.48%

Immix Biopharma Inc (IMMX)

Overview News Price History Financials Discussions Forecast

Immix Biopharma Inc stock is traded at $2.10, with a volume of 184.88K. It is down -5.41% in the last 24 hours and down -8.70% over the past month. Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Previous Close:

$2.22

Open:

$2.22

24h Volume:

184.88K

Relative Volume:

0.96

Market Cap:

$60.55M

Revenue:

Net Income/Loss:

$-14.14M

P/E Ratio:

-2.2826

EPS:

-0.92

Net Cash Flow:

$-12.64M

1W Performance:

-2.33%

1M Performance:

-8.70%

6M Performance:

+28.83%

1Y Performance:

+15.83%

1-Day Range:

$2.10

$2.22

1-Week Range:

$2.0894

$2.34

52-Week Range:

$1.26

$3.12

Immix Biopharma Inc Stock (IMMX) Company Profile

Name

Immix Biopharma Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(888) 958-1084

Address

11400 WEST OLYMPIC BLVD., LOS ANGELES

Employee

Twitter

Next Earnings Date

2025-09-03

Latest SEC Filings

IMMX's Discussions on Twitter

Compare IMMX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IMMX Immix Biopharma Inc	2.10	63.15M	0	-14.14M	-12.64M	-0.92
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Immix Biopharma Inc (IMMX)

Immix Biopharma Inc Stock (IMMX) Company Profile

Compare IMMX with other stocks

Immix Biopharma Inc Stock (IMMX) Latest News

How to interpret RSI for Immix Biopharma Inc. stockBull Run & Risk Controlled Swing Trade Alerts - Newser

Multi asset correlation models including Immix Biopharma Inc.2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser

Detecting price anomalies in Immix Biopharma Inc. with AIMarket Movement Recap & Risk Controlled Swing Trade Alerts - Newser

Historical volatility pattern of Immix Biopharma Inc. visualizedQuarterly Portfolio Review & Breakout Confirmation Trade Signals - Newser

News impact scoring models applied to Immix Biopharma Inc.Earnings Trend Report & Trade Opportunity Analysis Reports - Newser

Is Immix Biopharma Inc. forming a reversal patternOil Prices & Free Technical Pattern Based Buy Signals - Newser

Immix Biopharma Inc. stock trend outlook and recovery pathGDP Growth & AI Forecast Swing Trade Picks - Newser

Immix Biopharma stock price target raised to $8 from $7 at H.C. Wainwright - Investing.com

Immix Biopharma stock price target raised to $8 from $7 at H.C. Wainwright By Investing.com - Investing.com South Africa

Technical signs of recovery in Immix Biopharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - Newser

When is the best time to exit Immix Biopharma Inc.2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser

Will Immix Biopharma Inc. outperform the marketJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - Newser

Institutional scanner results for Immix Biopharma Inc.Weekly Trend Recap & AI Powered Trade Plan Recommendations - Newser

What’s the recovery path for long term holders of Immix Biopharma Inc.2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser

What Fibonacci levels say about Immix Biopharma Inc. reboundWeekly Gains Report & Fast Exit and Entry Trade Guides - Newser

is immix biopharma inc. forming a bottoming baseShare Buyback & Stock Portfolio Risk Management - Newser

Strategies to average down on Immix Biopharma Inc.Index Update & Low Drawdown Trading Techniques - Newser

Immix Biopharma, Inc. (NASDAQ:IMMX) Sees Significant Decrease in Short Interest - MarketBeat

Immix Biopharma Inc.’s volatility index tracking explainedJuly 2025 Highlights & Real-Time Volume Analysis - Newser

Combining price and volume data for Immix Biopharma Inc.July 2025 Catalysts & Community Verified Swing Trade Signals - Newser

Applying Wyckoff theory to Immix Biopharma Inc. stock2025 EndofYear Setup & Weekly Market Pulse Alerts - Newser

Immix Biopharma to Present at the Stifel 2025 Healthcare Conference - Investing News Network

Leading vs lagging indicators on Immix Biopharma Inc. performancePortfolio Gains Report & Daily Growth Stock Investment Tips - Newser

Real time alert setup for Immix Biopharma Inc. performanceOptions Play & Weekly Chart Analysis and Guides - Newser

Nancy T. Chang Joins Immix Biopharma Board of Directors as Founding Member of Goose Capital - Quiver Quantitative

Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors - GlobeNewswire

$5B Drug Pioneer and Former Tanox CEO Nancy Chang Joins Immix Biopharma Board After Success with XOLAIR® - Stock Titan

Tick level data insight on Immix Biopharma Inc. volatilityJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser

Key metrics from Immix Biopharma Inc.’s quarterly dataStock Surge & Community Consensus Stock Picks - Newser

Is Immix Biopharma Inc. stock reversal real or fakeJuly 2025 Summary & Safe Capital Preservation Plans - Newser

What high frequency data says about Immix Biopharma Inc.July 2025 Fed Impact & Verified Momentum Watchlists - Newser

How to forecast Immix Biopharma Inc. trends using time seriesMarket Performance Summary & Accurate Trade Setup Notifications - Newser

Visual trend scoring systems applied to Immix Biopharma Inc.July 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser

Can momentum traders help lift Immix Biopharma Inc.2025 Market Sentiment & Safe Entry Point Alerts - Newser

Should you hold or exit Immix Biopharma Inc. nowJuly 2025 Final Week & Risk Managed Investment Signals - Newser

Is Immix Biopharma Inc. showing signs of accumulation2025 Support & Resistance & Fast Entry Momentum Alerts - Newser

Ranking Immix Biopharma Inc. among high performing stocks via toolsJuly 2025 Momentum & Entry and Exit Point Strategies - Newser

Immix Biopharma Inc. stock trend forecast2025 Investor Takeaways & Daily Price Action Insights - Newser

Does Immix Biopharma Inc. have consistent dividend growth2025 Trade Ideas & Risk Managed Trade Strategies - Lancaster City Council

How to recover losses in Immix Biopharma Inc. stockEarnings Trend Report & Capital Efficient Trade Techniques - Newser

Immix Biopharma Inc Stock (IMMX) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to IMMX